Glaukos (GKOS) Share-based Compensation (2014 - 2026)
Glaukos' (GKOS) quarterly Share-based Compensation came in at $19.1 million in Q1 2026, up 47.42% year-on-year from $13.0 million in Q1 2025, and up 277.89% on a QoQ basis from $5.1 million in Q4 2025.
Glaukos (GKOS) Share-based Compensation (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Share-based Compensation data on file, last reported at $19.1 million in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 47.42% year-over-year to $19.1 million in Q1 2026; TTM through Mar 2026 was $39.7 million, a 4.65% increase from a year earlier, with the FY2025 full-year figure at $13.0 million, down 80.2% from the prior year.
- Share-based Compensation for Q1 2026 stood at $19.1 million, up from $5.1 million in the prior quarter.
- Over the last five years, Share-based Compensation for GKOS reached as high as $92.3 million in Q3 2025 and fell as low as -$27.3 million in Q4 2023.
- Historically, Share-based Compensation has averaged $8.5 million across 5 years, with a median of $5.1 million in 2025.
- Across the five-year window, Share-based Compensation tumbled 394.96% in 2023 and surged 1356.27% in 2024, its largest moves.
- Year by year, Share-based Compensation stood at -$20.4 million in 2022, then plunged by 33.7% to -$27.3 million in 2023, then soared by 106.34% to $1.7 million in 2024, then soared by 192.83% to $5.1 million in 2025, then surged by 277.89% to $19.1 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $19.1 million in Q1 2026, $5.1 million in Q4 2025, and $92.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 35.80 Mn |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn | 35.00 Mn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn | 35.12 Mn |
| 10 | Glaukos | 8.79 Bn | 8.68 Bn | 117.23 Mn | 19.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.14 Mn |
| Mar 31, 2026 | 19.14 Mn |
| Dec 31, 2025 | 5.07 Mn |
| Dec 31, 2025 | 5.07 Mn |
| Sep 30, 2025 | 92.30 Mn |
| Sep 30, 2025 | 92.30 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 12.99 Mn |
| Mar 31, 2025 | 12.99 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Sep 30, 2024 | 14.42 Mn |
| Sep 30, 2024 | 14.42 Mn |
| Jun 30, 2024 | 8.82 Mn |
| Jun 30, 2024 | 8.82 Mn |
| Mar 31, 2024 | 13.37 Mn |
| Mar 31, 2024 | 13.37 Mn |
| Dec 31, 2023 | -27.27 Mn |
| Dec 31, 2023 | -27.27 Mn |